Literature DB >> 21826094

Deep brain stimulation and neuropsychology: a step forward?

Alexander I Tröster.   

Abstract

Year:  2011        PMID： 21826094     DOI： 10.1038/nrneurol.2011.122

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.

Authors:  Thomas D Parsons; Steven A Rogers; Alyssa J Braaten; Steven Paul Woods; Alexander I Tröster
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

2.  Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.

Authors:  M K York; M Dulay; A Macias; H S Levin; R Grossman; R Simpson; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10-26       Impact factor: 10.154

3.  Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.

Authors:  Karsten Witt; Christine Daniels; Julia Reiff; Paul Krack; Jens Volkmann; Markus O Pinsker; Martin Krause; Volker Tronnier; Manja Kloss; Alfons Schnitzler; Lars Wojtecki; Kai Bötzel; Adrian Danek; Rüdiger Hilker; Volker Sturm; Andreas Kupsch; Elfriede Karner; Günther Deuschl
Journal:  Lancet Neurol       Date:  2008-06-04       Impact factor: 44.182

4.  Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery.

Authors:  Valerie Voon; Jean Saint-Cyr; Andres M Lozano; Elena Moro; Yu Yan Poon; Anthony E Lang
Journal:  J Neurosurg       Date:  2005-08       Impact factor: 5.115

5.  Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease.

Authors:  A M Strutt; R Simpson; J Jankovic; M K York
Journal:  Eur J Neurol       Date:  2011-06-11       Impact factor: 6.089

6.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

7.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

8.  A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.

Authors:  Valerie Voon; Paul Krack; Anthony E Lang; Andres M Lozano; Kathy Dujardin; Michael Schüpbach; James D'Ambrosia; Stephane Thobois; Filippo Tamma; Jan Herzog; Johannes D Speelman; Johan Samanta; Cynthia Kubu; Helene Rossignol; Yu-Yan Poon; Jean A Saint-Cyr; Claire Ardouin; Elena Moro
Journal:  Brain       Date:  2008-10       Impact factor: 13.501

9.  Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.

Authors:  Frances M Weaver; Kenneth Follett; Matthew Stern; Kwan Hur; Crystal Harris; William J Marks; Johannes Rothlind; Oren Sagher; Domenic Reda; Claudia S Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff Bronstein; Gatana Stoner; Jill Heemskerk; Grant D Huang
Journal:  JAMA       Date:  2009-01-07       Impact factor: 56.272

10.  Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease.

Authors:  Harriet M M Smeding; Johannes D Speelman; Hilde M Huizenga; P Richard Schuurman; Ben Schmand
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05-21       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.